Search results for "FDA update"

Results 1 - 10 of about 71 for "FDA update".
Sort by: Relevance | Newest | Oldest

FDA approves first medication for adults with hepatorenal syndrome

The treatment is indicated to improve kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function.
23 Sep 2022

Updated design, labeling cleared for duodenoscope

The changes aim to reduce the potential for patient fluids to leak into the closed elevator channel and underneath the distal cap.
23 Feb 2018

Boxed warning added to liver disease drug

The drug has been incorrectly dosed daily instead of weekly in patients with moderate to severe primary biliary cholangitis, which increases the risk of serious liver injury, the FDA said.
23 Feb 2018

Proton-pump inhibitor recalled

One lot of pantoprazole sodium for injection (40 mg per vial) was recalled in December.
26 Jan 2018

FDA restricts use of liver disease drug in certain patients

The agency added new warnings to the prescribing information for obeticholic acid, including a contraindication in patients with primary biliary cholangitis and advanced cirrhosis.
25 Jun 2021

FDA approves new drug for travelers' diarrhea

Compared to placebo, the drug significantly reduced symptoms in a randomized controlled trial of 264 adults with travelers' diarrhea in Guatemala and Mexico.
27 Nov 2018

Automated reprocessors validated for use in specific duodenoscopes

The FDA had requested validation testing data from all companies that have automated endoscope reprocessors labeled to reprocess endoscopes because of the potential association with patient infection.
27 Apr 2018

Data show higher-than-expected rates of duodenoscope contamination

While the number of medical device reports associated with patient infections has declined by 62% since peaking in 2015, the FDA and duodenoscope manufacturers continue to address issues around device reprocessing.
28 Dec 2018

First drug approved to treat thrombocytopenia in adults with chronic liver disease who are having a medical procedure

Patients who received the drug for five days had increased platelet counts compared to those taking placebo.
25 May 2018

FDA approves first fecal microbiota product

The product, which is prepared from donated, tested stool and administered rectally as a single dose, is indicated for the prevention of recurrent Clostridioides difficile infection in adults who have already completed antibiotic treatment for a recurrence.
23 Dec 2022

Result Page: Prev   1   2   3   4   5   6   7   Next